Dendritic cells as targets for therapy in rheumatoid arthritis.
Dendritic cells as targets for therapy in rheumatoid arthritis.
复制标题
DOI:
10.1038/nrrheum.2009.185
复制
发表时间:
2009-10
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Dendritic cells (DC) play a central role in the induction of immunity and also in tolerance in their role as professional antigen-presenting cells (APC). In the absence of DC, a fatal autoimmunity develops in animal models. While the role of DC has been investigated extensively in the pathogenesis of Rheumatoid arthritis (RA), it remains unclear if DC initiate autoimmunity in this disease. Nevertheless, evidence points towards a significant role for DC in its maintenance and progression. Current biological therapies of RA are designed to ameliorate disease by targeting downstream products of APC such as TNFα, IL-1 and IL-6. Emerging therapies for RA are exploiting the tolerogenic capacity of DC. “Tolerogenic” DC can be generated from myeloid precursors ex vivo, loaded with antigen and manipulated to suppress autoimmune responses in vivo, through the induction of activation induced cell death (AICD), anergy, and/or regulatory T cells. Cells that are primed by DC such as B cells, T helper (Th)-1(Th1) and Th17 cells, and which have been implicated in certain models of autoimmunity, are also being considered as additional targets for immune based therapy. Studies to validate these approaches to ameliorate autoimmunity will be necessary before they are applied in the clinic.
登录
查看更多内容
影响因子:
32.4
作者:
Jung, S;Unutmaz, D;Lang, RA
通讯作者:
Lang, RA
影响因子:
27.4
作者:
Brentano, F.;Ospelt, C.;Kyburz, D.
通讯作者:
Kyburz, D.
影响因子:
100.3
作者:
Bluestone, Jeffrey A.;Thomson, Angus W.;Weiner, Howard L.
通讯作者:
Weiner, Howard L.
影响因子:
15.3
作者:
Dhodapkar, M V;Steinman, R M;Krasovsky, J;Munz, C;Bhardwaj, N
通讯作者:
Bhardwaj, N
影响因子:
4.9
作者:
Jongbloed, SL;Lebre, MC;McInnes, IB
通讯作者:
McInnes, IB